Hossam’s Secrets of the Glycation-Hyperinsulinemia Interphase in Osteoarthritis with Suggestions of the Root Treatment: US Patents Review

Hossam Mohamed; Houda Almansour; Dalal Alsaadoun; Mariam Almansour; Sulaiman Alnassera; Yasmin Almansour

doi:doi:10.11648/j.frontiers.20220201.11

| Peer-Reviewed

Hossam’s Secrets of the Glycation-Hyperinsulinemia Interphase in Osteoarthritis with Suggestions of the Root Treatment: US Patents Review

Hossam Mohamed, Houda Almansour, Dalal Alsaadoun, Mariam Almansour, Sulaiman Alnassera, Yasmin Almansour

Published in Frontiers (Volume 2, Issue 1)

Received: 20 December 2021 Accepted: 7 January 2022 Published: 12 January 2022

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Osteoarthritis is by far the most common disease in the elderly. It has a great impact on the health care system in every nation. Its cost not only includes the price of the medication and surgery but there are other indirect costs in the form of sick leaves, disability, consumption of hospital resources, and others. The traditional treatment depends mainly on analgesics which always have many side effects and almost always fail because the disease usually progresses to a more advanced level. The surgical treatment may cure the pain but it is very expensive and still also has the side effects of the surgery itself. New US patents (US9433798), (US9452297), (US9757583) looked at this disease process from another view. They discovered that osteoarthritis is a small piece of many other parts of a generalized disease affecting the whole body. The root of this condition is in the visceral fat while its summit is the painful osteoarthritic joint. Extensive research was done on the link between the visceral fat and the painful arthritic joint. The visceral fat always occurred before the appearance of arthritis. Therefore, every possible method was exerted to abort this problem at its very early stage. This may even be before the start of the pain which is called the treatment at the root level. This creates a new line of treatment other than medication and surgery. Moreover, this may be physiological, effective, cheaper, and more functional as well.

Published in	Frontiers (Volume 2, Issue 1)
DOI	10.11648/j.frontiers.20220201.11
Page(s)	1-14
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Osteoarthritis, Visceral Fat, Glycation, Hyperinsulinemia, NF-kB, Infra-red Laser, PEMF

References

[1]	Kelsey H. Collins, 2021, Adipose tissue is a critical regulator of osteoarthritis. PANS. Vol 118 (1) e2021096118.
[2]	Shanshan Li. 2020. Association of Visceral Adiposity With Pain but Not Structural Osteoarthritis. Arthritis & Rheumatology Vol 72 (7): 1103-1110.
[3]	Neira, Rodrigo. 2002. Fat Liquefaction: Effect of Low-Level Laser Energy on Adipose Tissue. Plastic & Reconstructive Surgery. Volume 110 - Issue 3 - p 912-922.
[4]	Hossam Mohamed, 2017, Method of Fat Radiation by laser. USPTO, US 9,433,798, https://patents.google.com/patent/US9433798.
[5]	Yuze Wang, 2013, Nutrition and degeneration of articular cartilage. Knee Surgery Sports Traumatology Arthroscopy. Volume 21 (8): 1751–1762.
[6]	Ming-Feng Hsueh, 2016. Elucidating the Molecular Composition of Cartilage by Proteomics. Journal of Proteome Research. Volume 15 (2): 374–388.
[7]	Hossam Mohamed, 2017. Use of organic sulphur, antioxidants, and amino acids in conjunction with exercise and electromagnetic stimulation to treat osteoporosis. National Library of Medicine. https://pubchem.ncbi.nlm.nih.gov/patent/US9801905.
[8]	Wern Cui Chu, 2017. Distribution of pericellular matrix molecules in the temporomandibular joint and their chondroprotective effects against inflammation. International Journal of Oral Science volume 9, pages 43–52.
[9]	Jörg Jerosch. 2011. Effects of Glucosamine and Chondroitin Sulfate on Cartilage Metabolism in OA: Outlook on Other Nutrient Partners Especially Omega-3 Fatty Acids. International Journal of Rheumatology. Volume 2011 \|Article ID 969012.
[10]	R Braham, 2003. The effect of glucosamine supplementation on people experiencing regular knee pain. British Journal of sports medicine. Volume 37 (1). Page 45-49.
[11]	Ramesh C. Gupta. 2019. Hyaluronic Acid: Molecular Mechanisms and Therapeutic Trajectory. Frontiers Veterinary Science. Volume 6. Article 192.
[12]	Hemanth Akkiraju, 2015. Role of Chondrocytes in Cartilage Formation, Progression of Osteoarthritis and Cartilage Regeneration. Journal of Developmental Biology, 3 (4), 177-192.
[13]	Yuqing Zhang, 2010. Epidemiology of Osteoarthritis. Clinics in Geriatric Medicine. Volume 26 (3): 355–369.
[14]	D T Felson. 2000. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med. Vol. 133 (8) Pages 635-46.
[15]	Reva C. Lawrence. 2008. Estimates of the Prevalence of Arthritis and Other Rheumatic Conditions in the United States, Part II. Arthritis Rheumatology. Vol. 58 (1): 26–35.
[16]	Kevin Ki-Wai Ho. 2021. End-stage knee osteoarthritis with and without sarcopenia and the effect of knee arthroplasty – a prospective cohort study. BMC Geriatrics volume 21, Article number: 2.
[17]	Kate L. Lapane. 2015. Effects of prescription non-steroidal anti-inflammatory agents on symptoms and disease progression among patients with knee osteoarthritis. Arthritis Rheumatology. Volume 67 (3): 724–732.
[18]	Nicholas Yohe. 2018. Complications and Readmissions After Total Knee Replacement in Octogenarians and Nonagenarians. Geriatric Orthopedic Surgical Rehabilitation. Volume 9: page 1-7.
[19]	Jean-Yves Reginster. 2017. Pharmaceutical-grade Chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: the ChONdroitin versus CElecoxib versus Placebo Trial (CONCEPT). Clinical & epidemiological disease. Vol. 76: pages 1537-1543.
[20]	Toru Ogata. 2018. Effects of glucosamine in patients with osteoarthritis of the knee: a systematic review and meta-analysis. Clinical Rheumatology volume 37, pages2479–2487.
[21]	Steven Bowman. 2018. Recent advances in hyaluronic acid based therapy for osteoarthritis. Clinical & Transitional medicine. Volume 7 (1). article 6.
[22]	J DeGroot. 2004. Advanced glycation endproducts in the development of osteoarthritis. Arthritis Research Therapy. 2004; volume 6 (Suppl 3): article 78.
[23]	Timothy M. Griffin. 2016. Insulin Resistance: Releasing the Brakes on Synovial Inflammation and Osteoarthritis? Arthritis Rheumatology. Volume 68 (6): Pages 1330–1333.
[24]	Eva Thijssen. 2015. Obesity and osteoarthritis, more than just wear and tear: pivotal roles for inflamed adipose tissue and dyslipidaemia in obesity-induced osteoarthritis. Rheumatology, Volume 54, Issue 4, Pages 588–600.
[25]	Brian O. Diekman. 2013. Stem cell-based therapies for osteoarthritis: Challenges and opportunities. Curr Opin Rheumatol. Volume 25 (1): 119–126.
[26]	Yuxiang Jiang. 2018. A unipolar pulse electromagnetic field apparatus for magnetic therapy. IEEE. Volume: 21, Issue: 5. Pages 41-48.
[27]	Xingjia Mao. 2020. Mitochondria: Potential Targets for Osteoarthritis. Frontiers Medical Volume 7. e581402.
[28]	Zachary A. Marcum. 2010. Recognizing the Risks of Chronic Nonsteroidal Anti-Inflammatory Drug Use in Older Adults. Ann Longterm Care. Volume 18 (9): Pages 24–27.
[29]	William L. Healy, 2013. Complications of Total Knee Arthroplasty: Standardized List and Definitions of The Knee Society. Clin Orthop Relat Res. Volume 471 (1): 215–220.
[30]	Yves Henrotin. 2010. Chondroitin Sulfate in the Treatment of Osteoarthritis: From in Vitro Studies to Clinical Recommendations. Therapeutic Advances in Musculoskelet Diseases. Volume 2 (6): 335–348.
[31]	Carey-Beth James. 2001. A Review of Articular Cartilage Pathology and the Use of Glucosamine Sulfate. Journal of Athletic Training. volume 36 (4): 413–419.
[32]	Alberto Migliore, 2015. Effectiveness and utility of hyaluronic acid in osteoarthritis. Clinical Cases Mineral Bone Metabolism. Volume 12 (1): 31–33.
[33]	J. Chang. 2018. Systemic and local adipose tissue in knee osteoarthritis. Osteoarthritis and Cartilage. Volume 26, Issue 7, Pages 864-871.
[34]	Dylan D Thomas. 2019. Hyperinsulinemia: An Early Indicator of Metabolic Dysfunction. Journal of Endocrinal Society. Volume 3 (9): 1727–1747.
[35]	Qingxian Li. 2021. Hyperglycemia-induced accumulation of advanced glycosylation end products in fibroblast-like synoviocytes promotes knee osteoarthritis. Experimental & Molecular Medicine volume 53, pages1735–1747.
[36]	Di Chen. 2020. Runx2 plays a central role in Osteoarthritis development. Journal of Orthopedic translation. Volume 23: 132–139.
[37]	Tommaso Iannitti, 2013. Pulsed electromagnetic field therapy for management of osteoarthritis-related pain, stiffness and physical function: clinical experience in the elderly. Clin Interv Aging. Volume 8: 1289–1293.
[38]	Hossam Mohamed. 2016. 1. WO2016038410 - HYBRID INFRA-RED LASER AND PULSED ELECTROMAGNETIC MEDICAL APPARATUS AND METHODS OF USE. https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2016038410.
[39]	Hossam Mohamed. 2017. Method of use of hybrid infra-red laser and pulsed electromagnetic medical apparatus. https://patents.google.com/patent/US9757583B2/en.
[40]	Krithika Lingappan, 2017. NF-κB in Oxidative Stress. Curr Opin Toxicol. Vol. 7: Pages 81–86.
[41]	Stephen Schaffer. 2018. Effects and Mechanisms of Taurine as a Therapeutic Agent. Biomol Ther (Seoul). Vol. 26 (3): 225–241.
[42]	J. J. Romero, 2002. Stimulated emission, excited state absorption, and laser modeling of the Nd³⁺: Ca₃Ga₂Ge₃O₁₂ laser system. Journal of Applied Physics. Volume 91, Issue 4. Page 1754.

Cite This Article

Plain Text BibTeX RIS

APA Style

Hossam Mohamed, Houda Almansour, Dalal Alsaadoun, Mariam Almansour, Sulaiman Alnassera, et al. (2022). Hossam’s Secrets of the Glycation-Hyperinsulinemia Interphase in Osteoarthritis with Suggestions of the Root Treatment: US Patents Review. Frontiers, 2(1), 1-14. https://doi.org/10.11648/j.frontiers.20220201.11

Copy | Download

ACS Style

Hossam Mohamed; Houda Almansour; Dalal Alsaadoun; Mariam Almansour; Sulaiman Alnassera, et al. Hossam’s Secrets of the Glycation-Hyperinsulinemia Interphase in Osteoarthritis with Suggestions of the Root Treatment: US Patents Review. Frontiers. 2022, 2(1), 1-14. doi: 10.11648/j.frontiers.20220201.11

Copy | Download

AMA Style

Hossam Mohamed, Houda Almansour, Dalal Alsaadoun, Mariam Almansour, Sulaiman Alnassera, et al. Hossam’s Secrets of the Glycation-Hyperinsulinemia Interphase in Osteoarthritis with Suggestions of the Root Treatment: US Patents Review. Frontiers. 2022;2(1):1-14. doi: 10.11648/j.frontiers.20220201.11

Copy | Download

@article{10.11648/j.frontiers.20220201.11,
  author = {Hossam Mohamed and Houda Almansour and Dalal Alsaadoun and Mariam Almansour and Sulaiman Alnassera and Yasmin Almansour},
  title = {Hossam’s Secrets of the Glycation-Hyperinsulinemia Interphase in Osteoarthritis with Suggestions of the Root Treatment: US Patents Review},
  journal = {Frontiers},
  volume = {2},
  number = {1},
  pages = {1-14},
  doi = {10.11648/j.frontiers.20220201.11},
  url = {https://doi.org/10.11648/j.frontiers.20220201.11},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.frontiers.20220201.11},
  abstract = {Osteoarthritis is by far the most common disease in the elderly. It has a great impact on the health care system in every nation. Its cost not only includes the price of the medication and surgery but there are other indirect costs in the form of sick leaves, disability, consumption of hospital resources, and others. The traditional treatment depends mainly on analgesics which always have many side effects and almost always fail because the disease usually progresses to a more advanced level. The surgical treatment may cure the pain but it is very expensive and still also has the side effects of the surgery itself. New US patents (US9433798), (US9452297), (US9757583) looked at this disease process from another view. They discovered that osteoarthritis is a small piece of many other parts of a generalized disease affecting the whole body. The root of this condition is in the visceral fat while its summit is the painful osteoarthritic joint. Extensive research was done on the link between the visceral fat and the painful arthritic joint. The visceral fat always occurred before the appearance of arthritis. Therefore, every possible method was exerted to abort this problem at its very early stage. This may even be before the start of the pain which is called the treatment at the root level. This creates a new line of treatment other than medication and surgery. Moreover, this may be physiological, effective, cheaper, and more functional as well.},
 year = {2022}
}

Copy | Download

TY - JOUR
T1 - Hossam’s Secrets of the Glycation-Hyperinsulinemia Interphase in Osteoarthritis with Suggestions of the Root Treatment: US Patents Review
AU - Hossam Mohamed
AU - Houda Almansour
AU - Dalal Alsaadoun
AU - Mariam Almansour
AU - Sulaiman Alnassera
AU - Yasmin Almansour
Y1 - 2022/01/12
PY - 2022
N1 - https://doi.org/10.11648/j.frontiers.20220201.11
DO - 10.11648/j.frontiers.20220201.11
T2 - Frontiers
JF - Frontiers
JO - Frontiers
SP - 1
EP - 14
PB - Science Publishing Group
SN - 2994-7197
UR - https://doi.org/10.11648/j.frontiers.20220201.11
AB - Osteoarthritis is by far the most common disease in the elderly. It has a great impact on the health care system in every nation. Its cost not only includes the price of the medication and surgery but there are other indirect costs in the form of sick leaves, disability, consumption of hospital resources, and others. The traditional treatment depends mainly on analgesics which always have many side effects and almost always fail because the disease usually progresses to a more advanced level. The surgical treatment may cure the pain but it is very expensive and still also has the side effects of the surgery itself. New US patents (US9433798), (US9452297), (US9757583) looked at this disease process from another view. They discovered that osteoarthritis is a small piece of many other parts of a generalized disease affecting the whole body. The root of this condition is in the visceral fat while its summit is the painful osteoarthritic joint. Extensive research was done on the link between the visceral fat and the painful arthritic joint. The visceral fat always occurred before the appearance of arthritis. Therefore, every possible method was exerted to abort this problem at its very early stage. This may even be before the start of the pain which is called the treatment at the root level. This creates a new line of treatment other than medication and surgery. Moreover, this may be physiological, effective, cheaper, and more functional as well.
VL - 2
IS - 1
ER -

Copy | Download

Author Information

Hossam Mohamed

Medical & Research Department, Huda Health INC, Ottawa, Canada
Houda Almansour

Medical & Research Department, Huda Health INC, Ottawa, Canada
Dalal Alsaadoun

Internal Medicine Department, College of Medicine, King Faisal University, Alahsa, Saudi Arabia
Mariam Almansour

Department of Endocrinology, AlFaisalia Hospital, Alhafouf, Saudi Arabia
Sulaiman Alnassera

Department of Pharmacology and Toxicology, Unaizah College of Pharmacy, Qassim University, Qassim City, Saudi Arabia
Yasmin Almansour

Department of Palliative Care, Specialized King Fahad Hospital, Dammam, Saudi Arabia

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Hossam Mohamed, Houda Almansour, Dalal Alsaadoun, Mariam Almansour, Sulaiman Alnassera, et al. (2022). Hossam’s Secrets of the Glycation-Hyperinsulinemia Interphase in Osteoarthritis with Suggestions of the Root Treatment: US Patents Review. Frontiers, 2(1), 1-14. https://doi.org/10.11648/j.frontiers.20220201.11

Copy | Download

ACS Style

Hossam Mohamed; Houda Almansour; Dalal Alsaadoun; Mariam Almansour; Sulaiman Alnassera, et al. Hossam’s Secrets of the Glycation-Hyperinsulinemia Interphase in Osteoarthritis with Suggestions of the Root Treatment: US Patents Review. Frontiers. 2022, 2(1), 1-14. doi: 10.11648/j.frontiers.20220201.11

Copy | Download

AMA Style

Hossam Mohamed, Houda Almansour, Dalal Alsaadoun, Mariam Almansour, Sulaiman Alnassera, et al. Hossam’s Secrets of the Glycation-Hyperinsulinemia Interphase in Osteoarthritis with Suggestions of the Root Treatment: US Patents Review. Frontiers. 2022;2(1):1-14. doi: 10.11648/j.frontiers.20220201.11

Copy | Download

@article{10.11648/j.frontiers.20220201.11,
  author = {Hossam Mohamed and Houda Almansour and Dalal Alsaadoun and Mariam Almansour and Sulaiman Alnassera and Yasmin Almansour},
  title = {Hossam’s Secrets of the Glycation-Hyperinsulinemia Interphase in Osteoarthritis with Suggestions of the Root Treatment: US Patents Review},
  journal = {Frontiers},
  volume = {2},
  number = {1},
  pages = {1-14},
  doi = {10.11648/j.frontiers.20220201.11},
  url = {https://doi.org/10.11648/j.frontiers.20220201.11},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.frontiers.20220201.11},
  abstract = {Osteoarthritis is by far the most common disease in the elderly. It has a great impact on the health care system in every nation. Its cost not only includes the price of the medication and surgery but there are other indirect costs in the form of sick leaves, disability, consumption of hospital resources, and others. The traditional treatment depends mainly on analgesics which always have many side effects and almost always fail because the disease usually progresses to a more advanced level. The surgical treatment may cure the pain but it is very expensive and still also has the side effects of the surgery itself. New US patents (US9433798), (US9452297), (US9757583) looked at this disease process from another view. They discovered that osteoarthritis is a small piece of many other parts of a generalized disease affecting the whole body. The root of this condition is in the visceral fat while its summit is the painful osteoarthritic joint. Extensive research was done on the link between the visceral fat and the painful arthritic joint. The visceral fat always occurred before the appearance of arthritis. Therefore, every possible method was exerted to abort this problem at its very early stage. This may even be before the start of the pain which is called the treatment at the root level. This creates a new line of treatment other than medication and surgery. Moreover, this may be physiological, effective, cheaper, and more functional as well.},
 year = {2022}
}

Copy | Download